FOCL.US EDAP TMS S.A.

Healthcare Health Care Providers & Services USA Stocks
3.24 USD
Close of Nov 14, 2026
1.95 6.40
Market cap
USD 153M
P/E
-
P/B
4.53x
ROE
-104.0%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is FOCL.US undervalued?

Graham number

The Graham number of EDAP TMS S.A. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

EDAP TMS S.A. fundamental analysis

No fundamental analysis for EDAP TMS S.A. yet.

EDAP TMS S.A. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About EDAP TMS S.A.

EDAP TMS S.A., doing business as FocalTherics, operates as a medical technology company that develops, manufactures, markets, and sells non-invasive therapeutic ultrasound and energy-based medical devices in Asia, France, the United States, and internationally. The company develops, manufactures, markets, and distributes non-invasive robotic HIFU systems for urology-related and other indications. It also offers Focal One, a HIFU robotic system to treat patients diagnosed wit…

Full company profile